1st Jul 2008 07:00
TRISTEL plc
Grant of Patent in China
Tristel plc ("Tristel"), the AIM listed provider of infection and contamination control products, announces that it has been granted a Chinese Patent for its highly successful disinfectant wipe. The new patent, Chinese Patent no 200480021541.7, relates to Tristel's chlorine dioxide wipe which is widely used in the United Kingdom, Italy, Spain, throughout the Middle East and certain Asian markets for the decontamination of the medical instruments used in hospitals' ear, nose and throat, cardiology and ultrasound departments.
The wipe incorporates Tristel's patented chlorine dioxide chemistry which is highly effective in destroying all types of bacteria (including bacterial spores, tuberculosis, C. diff and MRSA), fungi and viruses and is one of a small group of sporicidal agents that is safe and easy to use.
Tristel's core product range of instrument disinfectants has become the market leader in the UK Acute & Private Hospital sector. They are used to decontaminate heat sensitive endoscopic and ultrasound instruments in over 375 hospitals, representing some 60 per cent of all UK NHS Acute & Private Hospitals.
Contacts:
|
Tristel plc |
|
|
Paul Swinney, Chief Executive |
Tel: 01638 721 500 |
|
|
|
|
Daniel Stewart & Company Plc |
|
|
Graham Webster |
Tel: 020 7776 6550 |
|
Parkgreen Communications Ltd |
Tel: 020 7479 7933 |
|
Paul McManus |
Mob: 07980 541 893 |
Related Shares:
Tristel